Marketers recognize that key opinion leader (KOL) management is a critical component of their professional marketing strategies. But how can you make the most of those relationships? NGP asked Eric Johnson, SVP of InsiteResearch, and Eric Ratinetz, SVP, Managed Market Strategies for M4 Bimark.
An increasing number of pharmaceutical companies and other health care providers are finding themselves subject to corporate integrity agreements (CIAs) in order to settle fraud and abuse cases with the federal government. CIAs require providers to a
Pharmaceutical companies can find themselves subject to corporate integrity agreements (CIAs) if the government discovers noncompliance of fraud and abuse. NGP asked Jayson Dukes of FTI Consulting what companies can do to help ensure a favorable resolution when subject to a CIA.
Over the past few years, KOL Management has continually garnered more attention. Historically, all companies have been involved in KOL Management in one form or another. Identifying KOLs, engaging KOLs and tracking payments are all part of KOL Manage